Laryngeal Malignancy Dr Vishal Sharma Overview Most common

  • Slides: 66
Download presentation
Laryngeal Malignancy Dr. Vishal Sharma

Laryngeal Malignancy Dr. Vishal Sharma

Overview • Most common head & neck malignancy in adults • Accounts for 25%

Overview • Most common head & neck malignancy in adults • Accounts for 25% of head & neck cancer • Accounts for 1% of all cancers • Peak incidence between 55 - 65 years of age • 10 : 1 male predilection

Sites & subsites of larynx Supraglottis • Suprahyoid epiglottis • Aryepiglottic fold • Arytenoid

Sites & subsites of larynx Supraglottis • Suprahyoid epiglottis • Aryepiglottic fold • Arytenoid • Infrahyoid epiglottis • Ventricular bands Glottis • Vocal cords • Anterior commissure • Posterior commissure Subglottis

Incidence Glottic: 60 -75% Supraglottic: 20 -30% Subglottis: 5 -10%

Incidence Glottic: 60 -75% Supraglottic: 20 -30% Subglottis: 5 -10%

 • Squamous cell carcinoma (85%) • Carcinoma in situ Type s • Verrucous

• Squamous cell carcinoma (85%) • Carcinoma in situ Type s • Verrucous carcinoma • Undifferentiated carcinoma • Adenocarcinoma • Miscellaneous carcinoma • Sarcoma

Risk factors • Tobacco • Alcohol • Industrial exposure • Radiation exposure • Laryngeal

Risk factors • Tobacco • Alcohol • Industrial exposure • Radiation exposure • Laryngeal keratosis • Laryngeal papilloma (HPV 16 & 18) • Gastro-esophageal reflux disease

Natural History Supraglottic tumors • More aggressive, early lymph node metastasis Subglottic tumors •

Natural History Supraglottic tumors • More aggressive, early lymph node metastasis Subglottic tumors • B/L disease & mediastinal extension Glottic tumors • Grow slower & metastasize late

History taking Progressive & continuous hoarseness Dysphagia Hemoptysis Referred otalgia Stridor Neck swelling

History taking Progressive & continuous hoarseness Dysphagia Hemoptysis Referred otalgia Stridor Neck swelling

Examination Indirect Laryngoscopy & Flexible Laryngoscopy to look for malignancy Examination of neck: for

Examination Indirect Laryngoscopy & Flexible Laryngoscopy to look for malignancy Examination of neck: for lymph node enlargement Laryngeal crepitus: absent in post-cricoid involvement Laryngeal cartilage splaying & tenderness: for cartilage involvement

Investigations Direct Laryngoscopy & biopsy: for supraglottic tumor Microlaryngoscopy & biopsy: glottic & subglottic

Investigations Direct Laryngoscopy & biopsy: for supraglottic tumor Microlaryngoscopy & biopsy: glottic & subglottic tumors Panendoscopy: for node metastasis of unknown origin Contact endoscopy using Toluidine blue: early detection CT scan: pre-epiglottic & paraglottic extension, cartilage involvement, extra-laryngeal spread Positron Emission Tomography: recurrent or residual

Epiglottis malignancy

Epiglottis malignancy

Ventricular band malignancy

Ventricular band malignancy

Glottic malignancy

Glottic malignancy

Glottic malignancy

Glottic malignancy

Subglottic malignancy

Subglottic malignancy

CT scan: Rt vocal cord tumor

CT scan: Rt vocal cord tumor

CT scan: cartilage invasion

CT scan: cartilage invasion

PET scan: neck node metastasis

PET scan: neck node metastasis

PET CT scan: laryngeal malignancy

PET CT scan: laryngeal malignancy

TNM Classification UICC (1997)

TNM Classification UICC (1997)

TX = cannot be assessed T 0: = no evidence Tis: carcinoma in situ

TX = cannot be assessed T 0: = no evidence Tis: carcinoma in situ T 1 = limited to one site, normal cord mobility T 2 = adjacent site OR impaired cord mobility T 3 = limited to larynx with hemilarynx fixation T 4 a = thyroid / cricoid cartilage, thyroid gland, soft tissue neck, trachea, esophagus

NX = regional lymph nodes cannot be assessed N 0 = no evidence of

NX = regional lymph nodes cannot be assessed N 0 = no evidence of regional lymph nodes N 1 = ipsilateral, single, < 3 cm N 2 a = ipsilateral, single, > 3 to 6 cm N 2 b = ipsilateral, multiple, < 6 cm N 2 c = bilateral or contralateral, < 6 cm N 3 = > 6 cm MX = regional lymph nodes cannot be assessed M 0 = no evidence of regional lymph nodes M 1 = presence of distant metastasis

Supraglottis: T 1 = 1 subsite, normal cord mobility T 2 = > 1

Supraglottis: T 1 = 1 subsite, normal cord mobility T 2 = > 1 adjacent subsites, no fixation of hemilarynx Glottis: 1 a = 1 vocal cord only, normal cord mobility 1 b = both vocal cords, normal cord mobility T 2 = supraglottis / subglottis; OR impaired cord mobility Subglottis: T 1 = limited to subglottis, normal cord mobility T 2 = extension to glottis OR impaired cord mobility

Stage 0 = Tis NO MO Stage I = T 1 NO MO Stage

Stage 0 = Tis NO MO Stage I = T 1 NO MO Stage II = T 2 NO MO Stage III = presence of T 3 or N 1 Stage IVA = presence of T 4 or N 2 Stage IVB = presence of N 3 Stage IVC = presence of M 1

Treatment of Laryngeal Malignancy

Treatment of Laryngeal Malignancy

Definitive Treatment • Radical Surgery • Radical Radiotherapy (6000 c. Gray over 6 weeks)

Definitive Treatment • Radical Surgery • Radical Radiotherapy (6000 c. Gray over 6 weeks) • Chemotherapy: 5 Fluorouracil & Cisplatin • Surgery with post-op Radiotherapy • Radical Radiotherapy with salvage surgery • Chemo-radiation (organ preservation)

Surgical Treatment

Surgical Treatment

Glottic malignancy n Cordectomy n Frontal vertical partial laryngectomy n Lateral vertical partial laryngectomy

Glottic malignancy n Cordectomy n Frontal vertical partial laryngectomy n Lateral vertical partial laryngectomy n Fronto-lateral vertical partial laryngectomy n Extended fronto-lateral partial laryngectomy n Conventional VPL (hemi-laryngectomy)

Cordectomy

Cordectomy

Frontal VPL

Frontal VPL

Lateral VPL

Lateral VPL

Fronto-lateral VPL

Fronto-lateral VPL

Subtotal bifrontal laryngectomy

Subtotal bifrontal laryngectomy

Conventional VPL: hemi -laryngectomy

Conventional VPL: hemi -laryngectomy

Extended hemi-laryngectomy

Extended hemi-laryngectomy

Supraglottic malignancy n Epiglottectomy n Supraglottic (horizontal partial) laryngectomy n Extended supraglottic laryngectomy Trans-glottic

Supraglottic malignancy n Epiglottectomy n Supraglottic (horizontal partial) laryngectomy n Extended supraglottic laryngectomy Trans-glottic malignancy n Subtotal laryngectomy (supra-cricoid laryngectomy with crico-hyoido-pexy) n Three-fourth laryngectomy n Near-total laryngectomy

Supraglottic Laryngectomy

Supraglottic Laryngectomy

Supraglottic Laryngectomy

Supraglottic Laryngectomy

Supraglottic Laryngectomy

Supraglottic Laryngectomy

Three-fourth Laryngectomy

Three-fourth Laryngectomy

Supra-cricoid Laryngectomy

Supra-cricoid Laryngectomy

Supra-cricoid Laryngectomy + Crico-hyoido-pexy

Supra-cricoid Laryngectomy + Crico-hyoido-pexy

Near-total Laryngectomy

Near-total Laryngectomy

Near-total Laryngectomy

Near-total Laryngectomy

Near-total Laryngectomy

Near-total Laryngectomy

Advanced malignancy 1. Total Laryngectomy n Narrow field: removal of entire larynx only n

Advanced malignancy 1. Total Laryngectomy n Narrow field: removal of entire larynx only n Wide field: removal of entire larynx, hyoid bone, partial pharynx, strap muscles & I/L thyroid lobe 2. Extended (widespread ) total laryngectomy: wide field total laryngectomy + resection of surrounding structures (base of tongue, pharynx, thyroid gland)

Narrow field total laryngectomy

Narrow field total laryngectomy

Total Laryngectomy

Total Laryngectomy

Repair of hypopharynx

Repair of hypopharynx

Inferior constrictor approximated

Inferior constrictor approximated

Permanent tracheostome

Permanent tracheostome

Laryngectomy specimens

Laryngectomy specimens

Treatment planning

Treatment planning

Supraglottis T 1 & T 2 tumor limited to supraglottis: Radiotherapy or Supraglottic laryngectomy

Supraglottis T 1 & T 2 tumor limited to supraglottis: Radiotherapy or Supraglottic laryngectomy T 2 tumor involving glottis: Supracricoid Laryngectomy or Radiotherapy T 3 & T 4 tumor: Total laryngectomy + post-operative Radiotherapy or Radical Radiotherapy with salvage surgery or Chemo-radiation

Glottis Tis (Ca in situ): Radiotherapy or Endoscopic excision T 1 a: Radiotherapy or

Glottis Tis (Ca in situ): Radiotherapy or Endoscopic excision T 1 a: Radiotherapy or Vertical Partial Laryngectomy T 1 b tumor: Radiotherapy or Supracricoid Laryngectomy T 2 supraglottis: Supracricoid Laryngectomy or RT T 2 involving subglottis: Near-total or Total Laryngectomy T 2 impaired cord mobility: Supracricoid Laryngectomy or RT T 3 & T 4 tumor: Total laryngectomy + post-operative RT or Chemo-radiation or Radical Radiotherapy with salvage surgery

Subglottis T 1: Total Laryngectomy + hemithyroidectomy or RT (? ) T 2: Total

Subglottis T 1: Total Laryngectomy + hemithyroidectomy or RT (? ) T 2: Total Laryngectomy + hemithyroidectomy T 3 & T 4: Total Laryngectomy + hemithyroidectomy + post-operative Radiotherapy Neck nodes N 0: B/L selective dissection of levels 2, 3 & 4 or B/L Radiotherapy N 1: B/L modified radical neck dissection N 2 & N 3: B/L modified radical neck dissection

Voice Rehabilitation

Voice Rehabilitation

A. Esophageal voice B. Artificial larynx: Pneumatic, Electrical C. Shunt technique 1. tracheo-hypopharyngeal shunt

A. Esophageal voice B. Artificial larynx: Pneumatic, Electrical C. Shunt technique 1. tracheo-hypopharyngeal shunt 2. esophago-tracheal shunt D. Valved devices for tracheo-esophageal puncture 1. Blom Singer prosthesis 2. Panje button device 3. Provox prosthesis E. Surgical reconstruction of larynx 1. Laryngeal replacement (Teflon, Dacron)

Electronic Larynx

Electronic Larynx

Tracheo-esophageal prosthesis

Tracheo-esophageal prosthesis

Palliative Care Used in later stages to ameliorate symptoms 1. Debulking surgery (Laser-assisted) 2.

Palliative Care Used in later stages to ameliorate symptoms 1. Debulking surgery (Laser-assisted) 2. Radiotherapy (short-course) 3. Chemotherapy 4. Tracheostomy 5. Counseling

Thank You

Thank You